Vaccine effectiveness
Several studies of vaccine effectiveness have been conducted in the UK which indicate that 2 doses of vaccine are between 65 and 95% effective at preventing symptomatic disease with COVID-19 with the Delta variant, with higher levels of protection against severe disease including hospitalisation and death. There is some evidence of waning of protection against infection and symptomatic disease over time, though protection against severe disease remains high in most groups at least 5 months after the second dose.
The “vaccines” are working.
They are a cure for Wuhan flu hysteria, not a vaccine for the flu.
Hysteria sufferers who get the vaccine overcome their hysteria, drop their precautions and get the flu.
The success of the vaccinations is measured by the number of vaccinated who get the flu
Same with proven safe Ivermectin